LD-2 disclosure · 1st Quarter - Report
PURDUE PHARMA LLP
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Government Relations Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; federal response to the COVID-19 crisis; prescription drug payment reform; and pharmaceutical supply chain.
LobbyistsBRIAN SUTTER · THOMAS WHARTON · EMILY ELIZABETH WILKINSON-HOLLAND
Covered position (BRIAN SUTTER): Staff Dir., W&M Health Subcommittee, Chairman Dave Camp April, 2013 - Dec. 2014; Professional Staff, W&M Health Subcommittee, Chairman Dave Camp, Jan. 2011 - April 2013;Leg Dir., Rep. Dave Camp, May '08 - Jan.,'11 Leg Asst.Rep Camp, Feb '03-May'08;
Covered position (THOMAS WHARTON): Health Legislative Assistant - Senator Joe Lieberman. May 2011 - June 2012 Senior Legislative Assistant - Congressman Dan Boren. July 2008 - June 2011
Covered position (EMILY ELIZABETH WILKINSON-HOLLAND): Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Bankruptcy
Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.
LobbyistsBRIAN SUTTER · THOMAS WHARTON · EMILY ELIZABETH WILKINSON-HOLLAND